These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8517668)

  • 1. Stereologically measured nuclear volume in comparison to two-dimensional nuclear morphometry, mitotic index and flow cytometry in predicting disease outcome in bladder cancer.
    Lipponen PK
    Anticancer Res; 1993; 13(2):529-32. PubMed ID: 8517668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
    Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
    Lipponen PK; Aaltomaa S
    J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image analysis of Ag-NOR proteins in transitional cell bladder cancer.
    Lipponen P
    J Pathol; 1993 Dec; 171(4):279-83. PubMed ID: 8158457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of classic and quantitative prognostic factors in colorectal cancer.
    Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
    Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas.
    Vindeløv LL; Christensen IJ; Engelholm SA; Guldhammer BH; Højgaard K; Sørensen BL; Wolf H
    Cytometry; 1995 Jun; 22(2):93-102. PubMed ID: 7587754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
    Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
    Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
    Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
    Lipponen P; Eskelinen M
    Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cathepsin D in transitional cell bladder tumours.
    Lipponen PK
    J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer.
    Lipponen PK
    J Pathol; 1995 Feb; 175(2):203-10. PubMed ID: 7738716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to count mitoses in bladder cancer grading?
    Lipponen PK; Eskelinen MJ
    Anticancer Res; 1991; 11(2):825-9. PubMed ID: 2064337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of nuclear area index in patients with bladder cancer.
    Yusup A; Kanamaru H; Aoki Y; Saikawa S; Moriyama N; Oyama N; Akino H; Okada K; Yokoyama O
    Int J Urol; 2004 Jun; 11(6):374-8. PubMed ID: 15157205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
    Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E
    Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.